Molecular and Functional Characterisation of Z-nucleic Acid-induced Signalling
This project aims to elucidate the mechanisms of ZBP1 activation by Z-nucleic acids to inform therapeutic strategies for modulating immune responses in autoinflammation, antiviral, and anticancer contexts.
Projectdetails
Introduction
Nucleic acids are potent activators of an immune response. Z-nucleic acids are poorly defined and thermodynamically unstable conformers of double-stranded RNA/DNA helices. Recently, others and our group showed that Z-nucleic acids are recognised by the nucleic acid sensor ZBP1, thereby inducing an antiviral immune response.
ZBP1 Activation and Implications
Activation of ZBP1 has also been shown to induce anticancer immunity, and it is becoming clear that chronic engagement of ZBP1 by endogenous Z-nucleic acids causes autoinflammatory pathology.
On top of that, a remarkably diverse set of cellular insults, ranging from pathogens and chemicals to genetic mutations, trigger ZBP1 activation. Despite its relevance in these important (patho)physiological events, knowledge on the fundamental principles that govern Z-nucleic acid-induced ZBP1 signalling is lacking.
Research Proposal
I here propose that ZBP1 perceives these widely different disturbances in cellular physiology by detecting the increased intracellular concentrations of Z-nucleic acids. Based on a newly developed ZBP1 activation model and using nanopore sequencing, structural biology, and chemical or genetic perturbation methods, we will:
- Characterise the molecular mechanisms that regulate Z-nucleic acid levels.
- Determine the biophysical determinants of ZBP1 activation.
- Map the ZBP1 downstream signalling network.
- Functionally validate our novel findings in cellular and in vivo models of ZBP1 activation.
Future Implications
The resulting detailed mechanistic understanding of ZBP1 function from single molecule to organism will enable us to develop future strategies for therapeutic interference with ZBP1-mediated immune responses, either negatively, to resolve autoinflammation, or positively, to promote antiviral or anticancer immunity.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.983.531 |
Totale projectbegroting | € 1.983.531 |
Tijdlijn
Startdatum | 1-4-2024 |
Einddatum | 31-3-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITEIT GENTpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Negative Regulation of Inflammatory Responses Revealed with Camelid NanobodiesThe project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses. | ERC Consolid... | € 1.997.828 | 2024 | Details |
Allosteric modulation of immune checkpoint complexes as a new mode of therapeutic intervention in immunotherapyThe project aims to develop novel Nanobodies as safe and effective modulators of immune checkpoint complexes for cancer and autoimmune diseases, potentially outperforming current therapies. | ERC Advanced... | € 2.499.674 | 2024 | Details |
NTase Products and Cyclic Nucleotide SignallingThis project aims to discover novel cyclic nucleotides and their signaling pathways in humans, focusing on uncharacterized nucleotidyltransferases to enhance immune responses and therapeutic options. | ERC Starting... | € 1.755.873 | 2024 | Details |
Targeting SWI/SNF-related chromatin remodelling defects in solid tumoursThis project aims to uncover and exploit synthetic lethal vulnerabilities in SWI/SNF-deficient tumours to enhance anti-tumour immune responses and develop novel immuno-oncology therapies. | ERC Starting... | € 1.499.887 | 2023 | Details |
Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and CancerThis project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets. | ERC Starting... | € 2.025.000 | 2022 | Details |
Negative Regulation of Inflammatory Responses Revealed with Camelid Nanobodies
The project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses.
Allosteric modulation of immune checkpoint complexes as a new mode of therapeutic intervention in immunotherapy
The project aims to develop novel Nanobodies as safe and effective modulators of immune checkpoint complexes for cancer and autoimmune diseases, potentially outperforming current therapies.
NTase Products and Cyclic Nucleotide Signalling
This project aims to discover novel cyclic nucleotides and their signaling pathways in humans, focusing on uncharacterized nucleotidyltransferases to enhance immune responses and therapeutic options.
Targeting SWI/SNF-related chromatin remodelling defects in solid tumours
This project aims to uncover and exploit synthetic lethal vulnerabilities in SWI/SNF-deficient tumours to enhance anti-tumour immune responses and develop novel immuno-oncology therapies.
Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and Cancer
This project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Computation driven development of novel vivo-like-DNA-nanotransducers for biomolecules structure identificationThis project aims to develop DNA-nanotransducers for real-time detection and analysis of conformational changes in biomolecules, enhancing understanding of molecular dynamics and aiding drug discovery. | EIC Pathfinder | € 3.000.418 | 2022 | Details |
Computation driven development of novel vivo-like-DNA-nanotransducers for biomolecules structure identification
This project aims to develop DNA-nanotransducers for real-time detection and analysis of conformational changes in biomolecules, enhancing understanding of molecular dynamics and aiding drug discovery.